2012 ACR/ARHP Annual Meeting Archives - Page 2 of 180

Abstract Number: 1077

p21 Promotes Inflammatory Arthritis Resolution by Facilitating Alternative Activation of Macrophages
Abstract Number: 1571

Pain and Fatigue in Adult Patients with Rheumatoid Arthritis – Associations with Demographic Factors, Disease Related Factors, Body Awareness, Emotional and Psychosocial Factors
Abstract Number: 2443

Pain and Function Outcomes in Systemic Lupus Erythematosus Hip and Knee Arthroplasty
Abstract Number: 866

Pain Is Associated with Telomere Shortening in Women with Fibromyalgia
Abstract Number: 962

Pain, Sleep Disturbance, and Depression Mediate the Association Between Body Mass Index and Fatigue in Fibromyalgia
Abstract Number: 1724

Pandemic Influenza Immunization in Primary Antiphospholipid Syndrome (PAPS): A Trigger to Autoantibody Production?
Abstract Number: 1604

Parity and the Risk of Developing Rheumatoid Arthritis: Results From the Swedish Epidemiological Investigation of Rheumatoid Arthritis Study
Abstract Number: 842

Partial and Complete Recovery From Proteinuria in Lupus Nephritis Patients Receiving Standard of Care Treatment
Abstract Number: 1537

Pathogenesis of Atherosclerosis in Granulomatosis Polyangiitis
Abstract Number: 504

Pathogenic Autoantibodies to the Anti-Muscarinic Type 3 Receptor Act by Competitive Inhibition of Acetylcholine-Mediated Receptor Signalling in Sjögren’s Syndrome
Abstract Number: 409

Pathway Analysis of Genome-Wide Association Studies On Rheumatoid Arthritis
Abstract Number: 2510

Patient and Provider Factors Associated with Compliance with Rheumatoid Arthritis Treatment Recommendations
Abstract Number: 2106

Patient Characteristics Associated with Discrepancies in Evaluator-Reported and Patient-Reported Outcomes in U.S. Veterans with Rheumatoid Arthritis
Abstract Number: 1527

Patient Global Assessments for Disease Activity Are Predictive of Future Flare in Granulomatosis with Polyangiitis (Wegener’s)
Abstract Number: 1468

Patient Perspective Informs Core Sets, Constructs of Metrics and Communication Tools for Patients with Connective Tissue Disease Related Interstitial Lung Disease
Abstract Number: 488

Patient Preferences for Biologic Treatments in Rheumatoid Arthritis
Abstract Number: 2098

Patient Report Outcomes Variance Between Centers Is Much Lower Than Physician and Laboratory Assessed Measures of Rheumatoid Arthritis Activity: Results From a Multinational Study
Abstract Number: 1526

Patient Reported Outcomes in ANCA-Associated Vasculitis. A Prospective Comparison Between Birmingham Vasculitis Activity Score and Routine Assessment of Patient Index Data 3
Abstract Number: 2606

Patient Reported Outcomes in Early Arthritis Patients
Abstract Number: 1925

Patient Satisfaction and Experience with Golimumab, Adalimumab, and Etanercept for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Abstract Number: 2099

Patient Self-Assessments and Selected Patient Reported Outcomes May Reliably Identify Rheumatoid Disease Flare in Early Rheumatoid Arthritis Patients
Abstract Number: 2102

Patient Versus Physician Global Assessments in Ethnic Patients Wtih Rheumatoid Arthritis
Abstract Number: 75

Patient-Reported Outcomes Associated with Achieving and Maintaining Low Disease Activity in Rheumatoid Arthritis
Abstract Number: 373

Patient-Reported Outcomes in Early Rheumatoid Arthritis Patients Failing to Achieve Stable Low Disease Activity: Comparing Addition of Adalimumab to Methotrexate Monotherapy with Maintenance On Adalimumab Plus Methotrexate
Abstract Number: 906

Patient-Rheumatologist Communication Concerning Medication and Disease Risks
Abstract Number: 2206

Patients Fulfilling the Imaging-Arm and Patients Fulfilling the HLA-B27+ Arm of the Assessment of Spondyloarthritis International Society Axial Spondyloarthritis Classification Criteria: Are They Similar?
Abstract Number: 140

Patients That Continue to Flare Despite Apparent Optimal Urate Lowering Therapy
Abstract Number: 2219

Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Show Similar Response Rates After One Year of Treatment with Etanercept – results of the Esther Trial
Abstract Number: 767

Patients with Early Inflammatory Arthritis Who Fulfil the 2010 American College Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis Have Increased Mortality Compared to Those Who Do Not: Results From the Norfolk Arthritis Register
Abstract Number: 1112

Patients with Erosive Osteoarthritis Have Less Extensive Synovitis Than Patients with Rheumatoid Arthritis On Histopathology
Abstract Number: 1162

Patients with Juvenile Idiopathic Arthritis From a Low Socio-Economic Background Perceive Their Disease Activity and Physical Limitations Higher Than Patients from a High Socio-Economic Background
Abstract Number: 1466

Patients with Systemic Sclerosis Are Dying of Non-Systemic Sclerosis Related Causes, However Interstitial Lung Disease Remains the Predominant Systemic Sclerosis Related Cause of Death
Abstract Number: 1485

Patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS) Present Esophageal and Anorectal Involvement: Data From a Single Centre
Abstract Number: 1904

Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy
Abstract Number: 461

Patterns of Tocilizumab Use, and Dosing Among Patients with Rheumatoid Arthritis in the Clinical Practice. Preliminary Analyses of ACT-Life Study
Abstract Number: 2398

Pauci-Immune Glomerulonephritis in the Elderly: Disease Severity and Outcomes
Abstract Number: 2325

PD-1 Signaling Promotes Suppressive Function of CD4⁺ Regulatory T Cells in (New Zealand Black x New Zealand White )F₁ Lupus-Prone Mice in a Dose-Dependent Manner
Abstract Number: 331

PDL241, a Novel Humanized Monoclonal Antibody, Reveals CD319 As a Therapeutic Target for Rheumatoid Arthritis
Abstract Number: 189

Pedal Swelling As a Characteristic Phenotype of the New Category of Autoinflammatory Disease Associated with NOD2 Gene Mutations
Abstract Number: 280

Pediatric Automated Neuropsychological Assessment Metrics As a Screening Tool for Neuropsychiatric Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 315

Pediatric Lupus Nephritis: Micrornas – Macro Inflammation
Abstract Number: 275

Pediatric Rheumatology Practitioners Experience with Biologics in Juvenile Dermatomyositis: Survey Results
Abstract Number: 2012

Pediatric Rheumatology Productivity: Results of the American Academy of Pediatrics 2010 Workforce Survey
Abstract Number: 2148

Peer to Peer Mentoring for Individuals with Early Inflammatory Arthritis: Feasibility Pilot
Abstract Number: 1657

Peg-IFNa/Ribavirin/Protease Inhibitor Combination Is Highly Effective in HCV-Mixed Cryoglobulinemia Vasculitis
Abstract Number: 160

Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial
Abstract Number: 1153

Perceived Health-Related Quality of Life and Its Determining Factors in Children with Recent-Onset JIA
Abstract Number: 2407

Perceptions of the Chronic Disease Self-Management Program Among Low Income African American Women with Lupus
Abstract Number: 2423

Perceptions Regarding Cardiovascular Risk Factors and Barriers to Risk Reduction Among African American Women with Lupus
Abstract Number: 441

Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Healthy Subjects At Elevated Risk for Future Rheumatoid Arthritis and Subjects with Established Disease
Abstract Number: 2232

Performance of Berlin Criteria in Patients with EARLY Spondyloarthritis
Abstract Number: 390

Performance of Criteria for Remission in a Long-Term Observational Study of Patients with Early Rheumatoid Arthritis
Abstract Number: 2035

Performance of Icbd (International Criteria for Behcet’s Disease) in Iranian Children with Behcet’s Disease
Abstract Number: 561

Performance of Magnetic Resonance Imaging in Detection of Chronic Structural Changes in Sacroiliac Joints As Compared to Conventional X-Rays in Axial Spondyloarthritis
Abstract Number: 1358

Performance of Remission Criteria and Activity Indices in Psoriatic Arthritis
Abstract Number: 2113

Performance of the New ACR/EULAR Classification Criteria for Rheumatoid arthritis– a Systematic Literature Review
Abstract Number: 950

Performance of Various Anti-Nuclear Antibody Methodologies in the Assessment of Autoimmune Connective Tissue Diseases
Abstract Number: 555

Performances of the ASAS Axial Spondyloarthritis Criteria for Diagnosis and Classification Purposes in Patients Visiting a Rheumatologist Because of Chronic Back Pain: The Declic Study
Abstract Number: 904

Perinatal Characteristics, Maternal Reproductive History and Juvenile Idiopathic Arthritis: A Case-Control Study
Abstract Number: 1219

Periodontal Disease Is Associated with Rheumatoid Arthritis but Its Severity Is Not Correlated with Rheumatoid Arthritis Disease Activity
Abstract Number: 2523

Periodontal Pathogens Directly Promote Autoimmune Experimental Arthritis by Inducing a Toll-Like Receptor 2 and Interleukin-1 Driven Th17 Response
Abstract Number: 235

Peripheral and Central Sensitization in Patients with Different Degree of Knee Osteoarthritis
Abstract Number: 2082

Peripheral and Local Effects of Anti-C5aR Treatment in the Collagen Induced Arthritis Model
Abstract Number: 1756

Peripheral Blood B Cell Subsets and BAFF/APRIL Receptor Expression, Together with Circulating BAFF and APRIL Levels, Are Disturbed in Rheumatoid Arthritis but Not in Ankylosing Spondylitis
Abstract Number: 631

Peripheral Neuropathy Due to Systemic Lupus Erythematosus (SLE) Itself: Incidence, Disease Risk Factors and Outcome
Abstract Number: 609

Peripheral Neuropathy in Systemic Lupus Erythematosus
Abstract Number: 1489

Peripheral Neuropathy: A Complication of Systemic Sclerosis
Abstract Number: 1929

Pernicious Anemia and Vitamin B-12 Deficiency in Autoimmune Disease: Neglecting the Feet Will Lead You Astray
Abstract Number: 832

Peroxisome Proliferator-Activated Receptor Gamma Agonist Treatment for Rheumatoid Arthritis: A Proof-of-Concept Randomized Controlled Trial
Abstract Number: 379

Persistency and Predictors of Persistency of Adalimumab Among Rheumatoid Arthritis (RA) Patients in a US Registry
Abstract Number: 1433

Persistent Dyslipidemia Is a Risk Factor of Progression to Chronic Kidney Disease in Patients with Lupus Nephritis
Abstract Number: 2173

Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in Reducing Disease Activity in Patients with Rheumatoid Arthritis
Abstract Number: 1515

Pharmacological Blockade of Adenosine A2A Receptors (A_2AR) Prevents Radiation-Induced Dermal Injury
Abstract Number: 1907

Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study
Abstract Number: 1144

Phenotypic Characterization of Childhood Onset Rheumatoid Arthritis
Abstract Number: 2192

Phenotypic Features of Sjögren’s Syndrome Among Patients with Low-Titer SSA/B Antibodies
Abstract Number: 51

Phosphodiesterase 4 Expression in Rheumatoid Arthritis Synovium and Anti-Inflammatory Effects of Apremilast On Synovial Fibroblasts
Abstract Number: 1750

Phosphoprotein Changes Induced with Epratuzumab, an Antibody Targeting CD22 On B Cells
Abstract Number: 1585

Physical Activity and Timing of Discharge From Physical Therapy Following Total Knee Replacement
Abstract Number: 2634

Physical Disability, Perceived Dependence and Depression in Older Women with Osteoarthriti
Abstract Number: 90

Physical Function, Pain and Fatigue Are Related to Sleep Disturbance in Females with Rheumatoid Arthritis
Abstract Number: 2061

Physician Variation in Documentation of Rheumatoid Arthritis Quality Measures and Evaluation of Relationship with Radiographic Progression
Abstract Number: 79

Physician’s Global Assessment Is Affected by Physician’s Age and Gender, but Not by Patient Age and Gender in Rheumatoid Arthritis Patients Treated in Routine Care. Data From the Danish Nationwide Danbio Registry
Abstract Number: 1083

Physicians’ Recommendations for Total Knee Arthroplasty in Younger Persons with Moderate Osteoarthritis
Abstract Number: 2086

PI3-Kinase Controls Inflammatory Bone Destruction by Regulating the Osteoclastogenic Potential of Myeloid Cells
Abstract Number: 451

Pilot Study of Stimulation of the Cholinergic Anti-Inflammatory Pathway with an Implantable Vagus Nerve Stimulation Device in Patients with Rheumatoid Arthritis
Abstract Number: 1530

Plasma Cell Analysis As a Biomarker for Disease Activity in Patients with Granulomatosis with Polyangiitis
Abstract Number: 888

Plasma Cells Express the Novel Cytokine Interleukin-36α in Psoriatic and Rheumatoid Arthritis Synovium
Abstract Number: 2122

Plasma chemerin as a Useful Marker for Disease Activity in Patients with Rheumatoid Arthritis
Abstract Number: 2348

Plasma Fibrinogen Better Identifies Persistent Disease Activity in Polymyalgia Rheumatica Than Either ESR or CRP
Abstract Number: 2382

Plasma Fibrinogen is an Accurate Marker of Disease Activity in Patients with Polymyalgia Rheumatica
Abstract Number: 680

Plasma Level of Galectin-3 Binding Protein Reflects Type I Interferon Activity and Is Highly Increased in Patients with Systemic Lupus Erythematosus
Abstract Number: 1495

Platelet Aggregability, Eicosanoid Biosynthesis and Oxidative Stress in Primary Raynaud’s Phenomenon and Systemic Sclerosis
Abstract Number: 2296

Platelet Release Products Mediate Endothelial Apoptosis: A Possible Role for Thrombospondin 1- CD36 Pathway in SSc-Endothelial Apoptosis
Abstract Number: 2500

Podocyte Injury in Membranous and Proliferative Lupus Nephritis: Distinct Underlying Mechanisms?
Abstract Number: 1193

Podoplanin Expression in Rheumatoid Stroma Correlates with Lymphoid Neogenesis and Is Downregulated by Anti-TNF-α Therapy
Abstract Number: 1183

Podoplanin-Mediated Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Platelets Modulates IL-8 Expression
Abstract Number: 1635

Polyarthritis Caused by TIARP (TNFAIP9) Deficiency Critically Dependent On Dysregulated STAT3, NF-κB Signaling and Cell Death in Macrophage
Abstract Number: 1079

Polyclonal CD4⁺Foxp3⁺treg Cells Induce TGFb-Dependent Tolerogenic Dendritic Cells That Suppress Murine Lupus-Like Syndrome
Abstract Number: 225

Polymyositis in HIV+ Patients Is Associated to Uncontrolled Viral Load
Abstract Number: 1486

Poor Outcome in Patients with Systemic Sclerosis and Myocardial Involvement: A Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance
Abstract Number: 2037

Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization
Abstract Number: 89

Poor to Moderate Performance of Patient Self-Report in Indentifying Periodontitis in Patients with Rheumatoid Arthritis
Abstract Number: 916

Population Incidence of Soft Tissue Knee Injury: Estimates From a Swedish Health Care Register
Abstract Number: 1197

Porphyromonas Gingivalis and the Pathogenesis of Rheumatoid Arthritis: Analysis of the Synovial Tissue and of Other Compartments
Abstract Number: 1204

Porphyromonas Gingivalis Antibody Responses and Clinical Associations in Patients with Early Rheumatoid Arthritis
Abstract Number: 823

Positive Effects of Tocilizumab On Bone Remodeling in Patients with Rheumatoid Arthritis
Abstract Number: 955

Post – Surgical Outcome Is Correlated with Pre – Surgical Symptoms of Fibromyalgia in Patients Undergoing Spinal Surgery
Abstract Number: 169

Post-Marketing Safety Surveillance Data Reveals Patterns of Use for Pegloticase in Refractory Chronic Gout
Abstract Number: 1590

Post-Operative Rehabilitation Provides Unmet Need for Better Patient Support and Advice Following Lumbar Spinal Fusion
Abstract Number: 806

Posterior Insula Combined Glutamate and Glutamine Is Associated with Pain in Fibromyalgia: A Replication Study
Abstract Number: 2511

Potential Barriers That Limit Access to Rheumatologists Among Patients with Early Rheumatoid Arthritis in a Universal Access Health Care System
Abstract Number: 762

Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
Abstract Number: 808

Power Doppler Is Predictive of Treatment Failure in Early Rheumatoid Arthritis Patients: A One Year Follow-up Study
Abstract Number: 113

Power Doppler Signal Is Frequently Positive Among Patients with Rheumatoid Arthritis in Clinical Remission and Normal Serum Matrix Metalloproteinase-3 (MMP-3) Levels
Abstract Number: 2587

Practice Makes Perfect: Assessment of Proficiency of Rheumatology Fellows in Specific Joint Procedural Skills
Abstract Number: 1540

Practice Patterns in the Treatment of ANCA-Associated Vasculitis: Exploring Differences Among Subspecialties At a Single Academic Medical Center
Abstract Number: 66

Pre-Rheumatoid Arthritis (pre-RA) Subjects Had a Minority Excess with Clearly Low Serum Cortisol Levels and Females Had Lower Mean Androstenedione Levels Than Control (CN) Cohorts in Analysis of a Large Panel of Serum Steroids and Pituitary Hormones
Abstract Number: 336

Preclinical Development of ALX-0061, an Anti-IL-6R Nanobody^®For Therapeutic Use in Rheumatoid Arthritis with a High in Vitro Affinity and Potency and a Competitive in Vivo Pharmacological Profile
Abstract Number: 2244

Predicting Sjögren’s Syndrome At Diagnosis of Systemic Lupus Erythematosus
Abstract Number: 87

Prediction of Mortality in Rheumatoid Arthritis Using a Serum Cytokine Profile
Abstract Number: 1119

Prediction of MRI-Detected Cartilage Loss Over 30 Months Using Simplified Radiographic and Clinical Stratification: The MOST Study
Abstract Number: 1706

Predictive Atherosclerotic Risk Factors At Inception in a Multicentre, Multinational Cohort
Abstract Number: 2593

Predictive Markers of Therapeutical Outcome and Their Role in the Ethiopathology of Juvenile Idiopathic Arthritis
Abstract Number: 1309

Predictive Risk Factors of Serious Infections in RA Patients Treated with Abatacept in Real Life: Results in the Orencia and Rheumatoid Arthritis (ORA) Registry
Abstract Number: 345

Predictive Software-Based Mathematical Modeling: A Novel Approach to Development of Oral Therapies for Rheumatoid Arthritis – Validation in a Murine Collagen Induced Arthritis Model
Abstract Number: 2120

Predictive Value of Anti-CCP Positivity On Disease Course and Response to Therapy in Early Rheumatoid Arthritis. Results From the Swedish EIRA Study
Abstract Number: 2567

Predictive Value of Selected Markers of Inflammation and Platelet Activation for Complete Remission in ANCA – Associated Vasculitis
Abstract Number: 1882

Predictors of a Favorable Outcome in Patients with Fibromyalgia: Results From the 1-Year Follow-up
Abstract Number: 1483

Predictors of Digital Ulcers in Systemic Sclerosis: Correlation Between Clinical and Hemodynamic Features, Capillaroscopy, Endothelium Dysfunction and Angiogenesis Biomarkers
Abstract Number: 1698

Predictors of Discontinuation of Biologics in 2,281 US Patients with Rheumatoid Arthritis
Abstract Number: 1371

Predictors of Erosion-Free Psoriatic Arthritis
Abstract Number: 1869

Predictors of Fatigue in Fibromyalgia
Abstract Number: 491

Predictors of Initiating Biologic Monotherapy in Biologic Naïve Patients with Rheumatoid Arthritis (RA) in a US Registry Population
Abstract Number: 1400

Predictors of Obesity in Systemic Lupus Erythematosus
Abstract Number: 1393

Predictors of Panniculitis in Systemic Lupus Erythematosus
Abstract Number: 1082

Predictors of Persistence in People with Subacute Low Back Pain
Abstract Number: 1819

Predictors of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Abstract Number: 826

Predictors of Return to Work During 3 Years After Start of First Tumor Necrosis Factor Antagonist in a National Cohort of Biologics-Treated Patients with Rheumatoid Arthritis
Abstract Number: 807

Predictors of Rheumatoid Arthritis: Quantitative and Semiquantitative Sonographic Measurements of Peripheral Joints
Abstract Number: 1301

Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial
Abstract Number: 1843

Predictors of Starting and Stopping Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis: A 23 Year Longitudinal Cohort
Abstract Number: 2610

Predictors of Sustained Clinical Remissionin Early Rheumatoid Arthritis – Results From the Canadian Early Arthritis Cohort
Abstract Number: 614

Predictors of Systemic Lupus Erythematosus Flares: Baseline Disease Activity and Demographic Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials
Abstract Number: 2283

Preferential Association of Complement Receptor 2 Variants with Anti-dsDNA Autoantibodies in Systemic Lupus Erythematosus
Abstract Number: 846

Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele up-Regulates IL10 Expression
Abstract Number: 1897

Pregnancy and Contraception in Adolescents and Teens with SLE: Are pediatric rheumatologists adequately Screening and Educating Their Patients?
Abstract Number: 2184

Pregnancy and Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome.
Abstract Number: 2466

Pregnancy Outcome in Women Treated with Adalimumab for the Treatment of Rheumatoid Arthritis: The OTIS Autoimmune Diseases in Pregnancy Project
Abstract Number: 349

Preliminary Results From a Controlled Study Assessing the Humoral Immune Response to Vaccines in Rheumatoid Arthritis Patients Treated with Tocilizumab
Abstract Number: 1835

Prescription of Biologics in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS) in 4 Norwegian Regions 2002-2011: A Study of Prescription Rates and Baseline Disease Activity
Abstract Number: 2540

Prescription of Tumour Necrosis Factor α Antagonists Is Strongly Associated with a Reduction in Hospital Admissions and in Musculoskeletal Surgical Procedures for Rheumatoid Arthritis Based On a 16 Year Analysis of Nationwide Data
Abstract Number: 2367

Presence of Fibromyalgia and Fatigue Is Not Increased in Patients with Takayasu’s Arteritis
Abstract Number: 252

Presence of Severe Medial Mensical Pathology Increases the Odds for Knee Replacement: Data From the Osteoarthritis Initiative
Abstract Number: 969

Presence of Small Fiber Neuropathy in a Cohort of Patients with Fibromyalgia
Abstract Number: 333

Pressure and Blood Flow Measurements in Efferent Lymphatics As Biomarkers of Arthritic Flare
Abstract Number: 1957

Prevalence and Associated Factors of Vitamin D Insufficiency and Deficiency in 4,793 Japanese Patients with Rheumatoid Arthritis
Abstract Number: 176

Prevalence and Associations of Hepatitis C Arthritis in Chronic Hepatitis C Virus Infection
Abstract Number: 2426

Prevalence and Characteristics of Sleep Problems in Rheumatoid Arthritis: A Systematic Review of the Literature
Abstract Number: 300

Prevalence and Clinical Significance of Hippocampal Atrophy in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1424

Prevalence and Clinical Significance of Severe Infection in Patients with Systemic Lupus Erythematosus: Preliminary Data From Relesser (Registry of lupus of the Spanish Society of Rheumatology)
Abstract Number: 562

Prevalence and Predictors of Significant Liver Fibrosis in Methotrexate Treated Rheumatoid and Psoriatic Arthritis Patients Using Transient Elastography (fibroscan)
Abstract Number: 1488

Prevalence and Risk Factors of Low Bone Mineral Density in Chinese Patients with Systemic Sclerosis: A Case-Control Study
Abstract Number: 2565

Prevalence of Anti-Neutrophil Cytoplasmic Antibodies in Infective Endocarditis: An Analysis of 109 Cases
Abstract Number: 1194

Prevalence of Anti-Peptidylarginine Deiminase Type 4 Antibodies in Rheumatoid Arthritis and Unaffected First-Degree Relatives in Indigenous North American Populations
Abstract Number: 374

Prevalence of Biologic Utilization Over Calendar Time Among Medicare Beneficiaries with Rheumatoid Arthritis
Abstract Number: 551

Prevalence of Enthesitis in Psoriatic Patients: Agreement Between Clinical and Power Doppler Ultrasonography Exploration and Its Implications for the Classification of Psoriatic Arthritis
Abstract Number: 2182

Prevalence of Fibromyalgia Is Increased in Primary Sjögren’s Syndrome Compared with SLE and Associated with Depression and Severe Vitamin D Deficiency
Abstract Number: 157

Prevalence of Gout Among Adults with Chronic Kidney Disease in the United States, 2009-10
Abstract Number: 1618

Prevalence of Inflammatory Sacroiliitis Assessed On MR Imaging of Inflammatory Bowel Disease: A Retrospective Study Performed On 186 Patients
Abstract Number: 683

Prevalence of Inhibitory or Non-Inhibitory Autoantibodies to Angiotensin Converting Enzyme 2 (ACE2) in Patients with Systemic Lupus Erythematosus
Abstract Number: 1132

Prevalence of Knee Pain in Ultramarathon Runners
Abstract Number: 145

Prevalence of Non-Gout Arthritis in Patients with Gout: Not As Sparing As Previously Thought
Abstract Number: 1855

Prevalence of Potential Drug-Drug and Drug-Condition Interactions in Fibromyalgia Patients Newly-Initiating Pregabalin or Duloxetine
Abstract Number: 567

Prevalence of Psoriasis and Psoriatic Arthritis in a Northern Population of Spain
Abstract Number: 579

Prevalence of Psoriatic Arthritis in Psoriasis Patients According to Newer Classification Criteria
Abstract Number: 1114

Prevalence of Radiographic and Symptomatic Hip Osteoarthritis in an Urban US Population: The Framingham Osteoarthritis Study
Abstract Number: 541

Prevalence of Sacroiliitis in the General Population: Comparative Analysis with Cutaneous Psoriasis and Psoriatic Arthritis
Abstract Number: 2185

Prevalence of Severe Extra-Glandular Manifestations in a Large Cohort of Patients with Primary Sjögren’s Syndrome
Abstract Number: 1700

Prevalence of Spondyloarthritis in Anterior Uveitis Patients: The Sentinel Study
Abstract Number: 1377

Prevalence of Spondyloarthritis-Related Comorbidities, Osteoporosis and Fractures in Ankylosing Spondylitis: a Systematic Literature Review
Abstract Number: 1129

Prevalence of Symptomatic Basilar Thumb Joint Osteoarthritis in the General Population
Abstract Number: 396

Prevalence, Concordance and Predictors of Early and Sustained Remission Assessed by Various Indices in the French Early Arthritis Espoir Cohort
Abstract Number: 2360

Prevalence, Management and Outcomes of PET Positive Large Vessel Vasculitis in Difficult to Treat PMR and GCA Patients
Abstract Number: 174

Prevalence, Risk Factors, and Functional Impact of Arthralgias Among Patients with Chronic Hepatitis C Virus Infection
Abstract Number: 958

Prevelance of Spondyloarthropathy in Fibromyalgia Patients
Abstract Number: 1325

Prevention of Joint Destruction in Patients with High Disease Activity or High C-Reactive Protein
Abstract Number: 153

Prevention of Recurrent Calcium Stones in Subjects with Hyperuricosuria: A Randomized Controlled Trial of Febuxostat Vs Allopurinol
Abstract Number: 1551

Primary Angiitis of the Central Nervous System: Description of the First 52 Adult Patients Enrolled in the French COVAC’ Cohort
Abstract Number: 935

Primary Care Preventive Services in Patients with Systemic Lupus Erythematosus Compared to Others in Their Community
Abstract Number: 1654

Primary Endpoint Failure in the Rituximab in ANCA-Associated Vasculitis Trial
Abstract Number: 1506

Primary Human Scleroderma Dermal Endothelial Cells Exhibit Defective Angiogenesis
Abstract Number: 2016

Primary Raynaud’s Phenomenon in a Multicenter Cohort of Italian Children and Adolescents: Which Prognostic Relevance for Serological Tests?
Abstract Number: 2456

Pro-Inflammatory and Pro-Thrombotic Markers in Persistently Antiphospholipid Antibody-Positive Patients with/without Systemic Lupus Erythematosus
Abstract Number: 4

Pro-Inflammatory Effect of Extracellular RNA On Synovial Fibroblasts From Patients with Rheumatoid Arthritis
Abstract Number: 2576

Production of Citrullinated Filaggrin-Specific IgG in Rheumatoid Arthritis Patients Is Associated with an Expansion of Citrullinated Filaggrin Tetramer-Binding Switched Memory Blood B Cells
Abstract Number: 575

Profiling of Response to Anti-TNFα Therapy by Serum Markers of Tissue Degradation End Products in Ankylosing Spondylitis Patients
Abstract Number: 914

Prognosis for the Year 2030: The Consultation Prevalence of Osteoarthritis in Sweden May Increase by 50%
Abstract Number: 2385

Prognostic Impact of HLA-B^*51 and HLA–A^*26:01 On Ocular Behcet’s Disease
Abstract Number: 1930

Progranulin Plays a Protective Role in the Pathogenesis of Inflammatory Bowel Disease
Abstract Number: 753

Progress Report On Development of Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies
Abstract Number: 824

Progressive Improvements in Cortical Mass and Thickness throughout the Hip Were Observed with Denosumab Treatment in the Freedom Trial
Abstract Number: 2660

Progressive Radiographic Joint Damage in Established Rheumatoid Arthritis: Common and Strongly Associated with Seropositivity
Abstract Number: 2462

Projecting the Direct Cost Burden of Osteoarthritis in Canada Using a Population-Based Microsimulation Model From [2010-2031]
Abstract Number: 1078

Prolactin Is Increased in Responders to Anti-TNFá Treatment and the Role of the Prolactin Receptor in Rheumatoid Arthritis
Abstract Number: 670

Prolidase Deficiency Induces Antibodies to Sm, Ro60 and Double Stranded DNA
Abstract Number: 1695

Prolonged Exposure to Subcutaneous and Intravenous Abatacept in Patients with Rheumatoid Arthritis Does Not Affect Rates of Infection, Malignancy and Autoimmune Events: Results From Pooled Clinical Trial Data
Abstract Number: 621

Prolonged Improvement of Systemic Lupus Erythematosus Following Systematic Administration of Rituximab and Cyclophosphamide
Abstract Number: 143

Proposed Gout Treatment Guidelines and Meeting Serum Urate and Flare Goals
Abstract Number: 1507

Propylthiouracil Reduces Fibrosis in Chronic Oxidant Stress Mouse Model of Scleroderma
Abstract Number: 2110

Prospective Assessement of Bone Texture Parameters At the Hand in Rheumatoid Arthritis
Abstract Number: 351

Prospective Follow-up of Tocilizumab Treatment in 764 Patients with Refractory Rheumatoid Arthritis: Tolerance and Efficacy Data From the French Registry Regate (REGistry –RoAcTEmra)
Abstract Number: 1199

Proteases Produced by Porphyromonas Gingivalis Can Cleave and Citrullinate Substrates Found in the Joint and Oral Mucosa: Implications for Autoimmunity in Rheumatoid Arthritis
Abstract Number: 2492

Protective and Pathogenic Effects of the IL-23 Family of Cytokines in Spondyloarthropathy in SKG Mice
Abstract Number: 22

Protective Properties of Conditioned Media From Adipose Stem Cells On Osteoarthritic Chondrocytes
Abstract Number: 1060

Protein Kinase C Inhibitor Generates Human Tolerogenic Dendritic Cells That Induce Tr1 and Foxp3⁺ Regulatory T Cells
Abstract Number: 2317

Protein Phosphatase 5 (PP5) Regulates Methylation Sensitive Gene Expression in CD4+ T Cells
Abstract Number: 2069

Proteinase Activated Receptor-4 Stimulation Promotes Leukocyte Adhesion in the Rat Knee Joint
Abstract Number: 582

Proteomic Analysis of Synovial Tissue: A Unique Tool to Predict Response to Anti-TNF Alpha Therapy in Patients with Inflammatory Arthritis
Abstract Number: 560

Proteomic Profiling of Synovial Fluid Reveals Candidate Psoriatic Arthritis Biomarkers
Abstract Number: 990

Proteomic Shotgun Analysis of Mesenchymal Stem Cells Reveals an Alterated Regulation of Proteosomal Proteins in Osteoarthritis Patients
Abstract Number: 218

Proteomics Study of a Phase 1b Trial with an Anti-IFN-α Monoclonal Antibody Indicates Association of Soluble Interleukin 2 Receptor with Type I Interferon Activity in Patients with Dermatomyositis or Polymyositis
Abstract Number: 2040

Provisions of Quality Driven Care in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 2527

Prozone Phenomenon Leads to Low IgG4 Concentrations in IgG4-Related Disease
Abstract Number: 536

Psoriasis and Psoriatic Arthritis in a Diverse Ethnic Cohort
Abstract Number: 1357

Psoriatic Arthritis and Biologic Therapy: Treatment Response, Drug Survival and Outcome After Switching
Abstract Number: 1026

Psoriatic Arthritis and Spondyloarthritis: Inflammation Assessed by “Head to Toe” Wholebody Magnetic Resonance Imaging – A Comparison with Clinical Joint Examination
Abstract Number: 1368

Psoriatic Arthritis in South Asians- Comparison with Caucasians of European Descent
Abstract Number: 1042

Psoriatic Arthritis Patients Assessed by Dynamic Contrast-Enhanced MRI in High Disease Versus Minimal Disease Activity State – a Cross-Sectional Study Correlating Conventional MRI and Clinical Composite Measures
Abstract Number: 2699

Psychosocial Stress and Complement Activation Product C4d On Reticulocytes in Patients with Systemic Lupus Erythematosus
Abstract Number: 1659

Ptpome Profile of Rheumatoid Arthritis Fibroblast-Like Synoviocytes: A Novel Role for the Tyrosine Phosphatase SHP-2 As a Modulator of Invasion and Survival
Abstract Number: 1463

Pulmonary Hypertension and Interstitial Lung Disease within Pharos: Impact of Extent of Fibrosis and Pulmonary Physiology On Cardiac Hemodynamic Parameters
Abstract Number: 644

Pulmonary Hypertension in Systemic Lupus Erythematosus: A 6-Year Follow-up Study Cohort
Abstract Number: 231

Pulmonary Hypertension in the Antisynthetase Syndrome
Abstract Number: 2176

Pulmonary Manifestations and Treatment of Primary Sjogren’s Syndrome-Associated Lung Involvement Patients: A Prospective Study
Abstract Number: 1728

Purified IgG From Antiphospholipid Syndrome Patients with Pregnancy Morbidity Alone Inhibit Trophoblast Migration and Activate a TLR4 MyD88 Independent Pathway